Experiment 815487
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV INFUSION |
| Organism | Maytenus buchananii (CELASTRACEAE) |
| Citation | EAGAN,RT: CREAGAN,ET: INGLE,JN: FRYTAK,S: RUBIN,J:. (1978). PHASE II EVALUATION OF MAYTANSINE IN PATIENTS WITH METASTATIC LUNG CANCER.. 62() |
| Amount utilized | |
| Compound isolated | |
| Disease | PHASE II CLINICAL TRIAL INVOLVING 47 EVALUABLE CANCER PATIENTS WITH ADVANCED LUNG CANCER OVERALL TUMOR REGRESSION WAS 8% CONCLUSION WAS THAT MORE FREQUENT TREATMENT WOULD BE MORE BENEFICIAL |
| Dose amount | 0.6 MG |
| Number | 1 |
| Qualitative result | WEAK ACTIVITY |
| Animal | HUMAN ADULT |
| Per unit | SQ M BODY SURFACE |
| Dose expression | DOSE |
| Gender | GIVEN TO BOTH SEXES |